-
Product Insights
New![]()
Net Present Value Model: KemPharm Inc’s KP-1077
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KP-1077 in Narcolepsy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.KP-1077 in Narcolepsy Drug Details: KP-1077 is under development for the treatment of idiopathic hypersomnia (IH)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KP-1077 in Hypersomnia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KP-1077 in Hypersomnia Drug Details: KP-1077 is under development for the treatment of idiopathic hypersomnia...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KP-483 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KP-483 in Solid Tumor Drug Details: KP-483 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KP-910 in Peripheral Neuropathic Pain
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KP-910 in Peripheral Neuropathic Pain Drug Details: KP-910 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KP-879 in Substance (Drug) Abuse
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.KP-879 in Substance (Drug) Abuse Drug Details:KP-879 (prodrug of d-methylphenidate) is under development for the treatment...
-
Product Insights
KP Poligon – Volodymyr-Volynskyi Nezalezhnosti Street Overhaul – Volyn
Equip yourself with the essential tools needed to make informed and profitable decisions with our KP Poligon - Volodymyr-Volynskyi Nezalezhnosti Street Overhaul - Volyn report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Lvivvodokanal KP – Metalistiv Street Water Supply And Sewerage Networks Renovation – Lviv
Equip yourself with the essential tools needed to make informed and profitable decisions with our Lvivvodokanal KP - Metalistiv Street Water Supply And Sewerage Networks Renovation - Lviv report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
Lvivvodokanal KP – Yanovskoho Street Water Supply and Sewerage Network Development – Lviv
Equip yourself with the essential tools needed to make informed and profitable decisions with our Lvivvodokanal KP - Yanovskoho Street Water Supply and Sewerage Network Development - Lviv report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
KP Isberg Const – 183 Avenue Mixed-Use Condominium Building – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our KP Isberg Const - 183 Avenue Mixed-Use Condominium Building - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
KP Tissue/ Kruger Prod – Sherbrooke Tissue Paper Manufacturing Plant Expansion – Quebec
Equip yourself with the essential tools needed to make informed and profitable decisions with our KP Tissue/ Kruger Prod - Sherbrooke Tissue Paper Manufacturing Plant Expansion - Quebec report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
CLP Power India/ KP Energy – Dwarka Wind Power Plant 252 MW – Gujarat
Equip yourself with the essential tools needed to make informed and profitable decisions with our CLP Power India/ KP Energy - Dwarka Wind Power Plant 252 MW - Gujarat report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Iptacopan Hydrochloride in Glomerulonephritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Iptacopan Hydrochloride in Glomerulonephritis Drug Details: Iptacopan (LNP-023) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ASTX-295 in Dedifferentiated Liposarcoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ASTX-295 in Dedifferentiated LiposarcomaDrug Details:ASTX-295 is under development for the treatment of advanced metastatic and refractory...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TAK-102 in Neuroendocrine Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TAK-102 in Neuroendocrine CarcinomaDrug Details:TAK-102 (NIB-102) is under development for treatment of solid tumor including neuroendocrine...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Bria-IMT in Metastatic Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Bria-IMT in Metastatic Breast Cancer Drug Details: Bria-IMT (BriaVax) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SHR-1316 in Non-Small Cell Lung Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SHR-1316 in Non-Small Cell Lung Carcinoma Drug Details:SHR-1316 is under development for the treatment of advanced...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CTX-110 in Diffuse Large B-Cell Lymphoma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. CTX-110 in Diffuse Large B-Cell Lymphoma Drug Details: CTX-110 (previously known as CTX-101) is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Anamorelin Hydrochloride in Cancer Anorexia-Cachexia Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Anamorelin Hydrochloride in Cancer Anorexia-Cachexia SyndromeDrug Details: Anamorelin hydrochloride (Adlumiz) is a synthetic, small-molecule ghrelin mimetic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – QBS-10072S in Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. QBS-10072S in Ovarian Cancer Drug Details: QBS-10072S is under development for the treatment of solid...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.